Trial Profile
Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Sep 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Polypoidal choroidal vasculopathy
- Focus Therapeutic Use
- 02 Sep 2018 Status changed from recruiting to completed.
- 25 Mar 2014 New trial record